By exploring the expression of molecules involved in the insulin pathway in the endometria from PCOS patients, Fornes et al. found that patients with hyperinsulinemia lack some of the insulin receptor substrates, which disrupts glucose metabolism in the endometrium and impairs endometrial receptivity (Fornes et al., 2010). The gene discussed is INS; the disease is hyperinsulinism.